Dose Escalation Study of RSLV-132 in Subjects With Systemic Lupus Erythematosus
| Status: | Completed |
|---|---|
| Conditions: | Lupus |
| Therapuetic Areas: | Immunology / Infectious Diseases |
| Healthy: | No |
| Age Range: | 18 - 70 |
| Updated: | 4/21/2016 |
| Start Date: | July 2014 |
| End Date: | November 2015 |
A Double-Blind, Placebo-Controlled Dose Escalation Study of the Administration of Multiple Intravenous Doses of RSLV-132 in Subjects With Systemic Lupus Erythematosus
A one month multi-dose study will evaluate the safety and tolerability of 3 intravenous
infusions of RSLV-132 in subjects with inactive to mild SLE.
infusions of RSLV-132 in subjects with inactive to mild SLE.
Inclusion Criteria:
- Stable SLE with no anticipated change in medications for the next 60 days
Exclusion Criteria:
- Other biologic drugs
We found this trial at
4
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials